3-10289785-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016362.5(GHRL):c.202G>T(p.Ala68Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,609,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016362.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GHRL | NM_016362.5 | c.202G>T | p.Ala68Ser | missense_variant | 4/6 | ENST00000335542.13 | NP_057446.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GHRL | ENST00000335542.13 | c.202G>T | p.Ala68Ser | missense_variant | 4/6 | 1 | NM_016362.5 | ENSP00000335074.8 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151874Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251386Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135872
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1457818Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 725550
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151874Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74180
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.202G>T (p.A68S) alteration is located in exon 3 (coding exon 2) of the GHRL gene. This alteration results from a G to T substitution at nucleotide position 202, causing the alanine (A) at amino acid position 68 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at